CY1108314T1 - Σκευασμα για στοματικη χορηγηση εχοντας μια δραση που προαγει την υγεια επι του καρδιαγγειακου συστηματος - Google Patents
Σκευασμα για στοματικη χορηγηση εχοντας μια δραση που προαγει την υγεια επι του καρδιαγγειακου συστηματοςInfo
- Publication number
- CY1108314T1 CY1108314T1 CY20081100945T CY081100945T CY1108314T1 CY 1108314 T1 CY1108314 T1 CY 1108314T1 CY 20081100945 T CY20081100945 T CY 20081100945T CY 081100945 T CY081100945 T CY 081100945T CY 1108314 T1 CY1108314 T1 CY 1108314T1
- Authority
- CY
- Cyprus
- Prior art keywords
- oral administration
- health
- healthcare system
- health activity
- effect
- Prior art date
Links
- 230000008821 health effect Effects 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
- UOTMYNBWXDUBNX-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinolin-2-ium;chloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 UOTMYNBWXDUBNX-UHFFFAOYSA-N 0.000 abstract 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 abstract 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 abstract 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 235000013793 astaxanthin Nutrition 0.000 abstract 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 abstract 1
- 229940022405 astaxanthin Drugs 0.000 abstract 1
- 239000001168 astaxanthin Substances 0.000 abstract 1
- 210000000748 cardiovascular system Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 235000017471 coenzyme Q10 Nutrition 0.000 abstract 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 abstract 1
- 229940110767 coenzyme Q10 Drugs 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 210000003038 endothelium Anatomy 0.000 abstract 1
- 235000019152 folic acid Nutrition 0.000 abstract 1
- 229960000304 folic acid Drugs 0.000 abstract 1
- 239000011724 folic acid Substances 0.000 abstract 1
- 229940057059 monascus purpureus Drugs 0.000 abstract 1
- 229960001109 policosanol Drugs 0.000 abstract 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
- C09B67/0097—Dye preparations of special physical nature; Tablets, films, extrusion, microcapsules, sheets, pads, bags with dyes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Σύνθεση για στοματική χορήγηση, έχοντας μια δράση που προάγει την υγεία επί του καρδιαγγειακού συστήματος, περιέχοντας σαν ενεργά συστατικά μια πολυκοσανόλη ή ένα μίγμα πολυκοσανολών, ερυθρά ζύμη και ένα παράγοντα που επιλέγεται από την ασταξανθίνη και το φολικό (ή φιλικό) οξύ, κατά προτίμηση σε συνδυασμό με το συνένζυμο Q10. Η σύνθεση μπορεί να χρησιμοποιηθεί συγκεκριμένα για τη παρασκευή διατροφικών συμπληρωμάτων που έχουν δράσεις που προάγουν την υγεία, όπως (μια) ευλιπιδαιμική δράση, τη διόρθωση της ομοκυστεϊναιμίας, (μια) αντιοξειδωτική δράση και μια προστατευτική δράση επί του αγγειακού ενδοθηλίου.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000682A ITTO20040682A1 (it) | 2004-10-07 | 2004-10-07 | Formulazione per somministrazione orale avente un effetto salutistico sull'apparato cardiovascolare |
EP05792107A EP1827136B1 (en) | 2004-10-07 | 2005-09-20 | Formulation for oral administration having a health-promoting effect on the cardiovascular system |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1108314T1 true CY1108314T1 (el) | 2014-02-12 |
Family
ID=35395774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081100945T CY1108314T1 (el) | 2004-10-07 | 2008-09-03 | Σκευασμα για στοματικη χορηγηση εχοντας μια δραση που προαγει την υγεια επι του καρδιαγγειακου συστηματος |
Country Status (13)
Country | Link |
---|---|
US (1) | US20080102082A1 (el) |
EP (1) | EP1827136B1 (el) |
AT (1) | ATE397389T1 (el) |
CY (1) | CY1108314T1 (el) |
DE (1) | DE602005007380D1 (el) |
DK (1) | DK1827136T3 (el) |
ES (1) | ES2308550T3 (el) |
IT (1) | ITTO20040682A1 (el) |
PL (1) | PL1827136T3 (el) |
PT (1) | PT1827136E (el) |
SI (1) | SI1827136T1 (el) |
TW (1) | TWI359667B (el) |
WO (1) | WO2006037725A1 (el) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI323312B (en) * | 2005-06-23 | 2010-04-11 | Honda Motor Co Ltd | Gas-liquid separation device of engine |
ITTO20060239A1 (it) | 2006-03-30 | 2007-09-30 | Rotthapharm S P A | Formulazione per somministrazione orale con effetti salutistici sull'apparato cardiovascolare |
US20120171285A1 (en) * | 2007-06-01 | 2012-07-05 | Opheim Joar A | Substances for reducing occurrence of major cardiac events comprising omega-3 polyunsaturated fatty acid or derivatives thereof and high-monacolin k content red yeast rice extract |
US20100119600A1 (en) * | 2007-06-01 | 2010-05-13 | Joar Opheim | Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof |
FR2950061B1 (fr) | 2009-09-11 | 2013-12-20 | Coatex Sas | Monomeres associatifs a base de polycosanols, epaississants associatifs correspondants et leurs utilisations |
ITMI20121696A1 (it) * | 2012-10-09 | 2014-04-10 | Ddf Group S A S | Composizioni per il trattamento delle iperlipidemie |
ITUB20150541A1 (it) | 2015-03-03 | 2016-09-03 | Acraf | Composizione comprendente sostanze e/o estratti naturali |
CN105878801A (zh) * | 2016-05-10 | 2016-08-24 | 胡铭 | 一种具有降血脂作用的红曲虾青素组合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5952393A (en) * | 1998-02-12 | 1999-09-14 | Sorkin, Jr.; Harlan Lee | Composition for reducing serum cholesterol levels |
US20030104090A1 (en) * | 2000-05-05 | 2003-06-05 | Levy Pedro E. | Supplements containing annatto extracts and carotenoids and methods for using the same |
US6436406B1 (en) * | 2000-06-15 | 2002-08-20 | A. Glenn Braswell | Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis |
US6300377B1 (en) * | 2001-02-22 | 2001-10-09 | Raj K. Chopra | Coenzyme Q products exhibiting high dissolution qualities |
US20030054978A1 (en) * | 2001-08-31 | 2003-03-20 | Babish John G. | Arginine compositions for coordinate modification of multiple cardiovascular risk factors |
-
2004
- 2004-10-07 IT IT000682A patent/ITTO20040682A1/it unknown
-
2005
- 2005-09-20 AT AT05792107T patent/ATE397389T1/de active
- 2005-09-20 WO PCT/EP2005/054691 patent/WO2006037725A1/en active IP Right Grant
- 2005-09-20 PT PT05792107T patent/PT1827136E/pt unknown
- 2005-09-20 DK DK05792107T patent/DK1827136T3/da active
- 2005-09-20 US US11/576,644 patent/US20080102082A1/en not_active Abandoned
- 2005-09-20 SI SI200530379T patent/SI1827136T1/sl unknown
- 2005-09-20 ES ES05792107T patent/ES2308550T3/es active Active
- 2005-09-20 PL PL05792107T patent/PL1827136T3/pl unknown
- 2005-09-20 DE DE602005007380T patent/DE602005007380D1/de active Active
- 2005-09-20 EP EP05792107A patent/EP1827136B1/en not_active Not-in-force
- 2005-10-05 TW TW094134749A patent/TWI359667B/zh active
-
2008
- 2008-09-03 CY CY20081100945T patent/CY1108314T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL1827136T3 (pl) | 2008-11-28 |
WO2006037725A1 (en) | 2006-04-13 |
TWI359667B (en) | 2012-03-11 |
ITTO20040682A1 (it) | 2005-01-07 |
DE602005007380D1 (de) | 2008-07-17 |
PT1827136E (pt) | 2008-09-09 |
US20080102082A1 (en) | 2008-05-01 |
DK1827136T3 (da) | 2008-09-15 |
ES2308550T3 (es) | 2008-12-01 |
EP1827136A1 (en) | 2007-09-05 |
ATE397389T1 (de) | 2008-06-15 |
TW200621272A (en) | 2006-07-01 |
SI1827136T1 (sl) | 2008-12-31 |
EP1827136B1 (en) | 2008-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108314T1 (el) | Σκευασμα για στοματικη χορηγηση εχοντας μια δραση που προαγει την υγεια επι του καρδιαγγειακου συστηματος | |
DK2007429T3 (da) | Oralt præparat med gavnlige cardiovaskulære virkninger indeholdende berberin | |
GB2459809A (en) | Fatty acid formulations and methods of use thereof | |
MY143795A (en) | Tetrahydropyridoindole derivatives | |
NZ612504A (en) | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents | |
MY176018A (en) | Composition useful for the treatment of lipid metabolism disorders | |
BR112012033666A2 (pt) | formulações para alimentação por tubo e métodos de uso das mesmas | |
BR112012019190A2 (pt) | composições de cuidado oral. | |
MX2011007817A (es) | Formulacion farmaceutica o alimenticia de liberacion controlada y proceso para su preparacion. | |
WO2011116220A3 (en) | Oral supplement | |
WO2010041832A3 (ko) | 패 유래 화합물 함유 항산화 활성 조성물 | |
WO2012145575A3 (en) | Therapy for leukemia | |
WO2014082027A3 (en) | Antioxidant dietary supplement | |
WO2012151279A3 (en) | Induction of il-12 using immunotherapy | |
MX342417B (es) | Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales. | |
WO2013022312A3 (ko) | C y p 4 a 저해제를 유효성분으로 함유하는 당뇨병 또는 지방간의 예방 또는 치료용 약학적 조성물 | |
AU2012345659A8 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
WO2011141113A3 (de) | Kombination aus vitamin k und nikotinamid | |
MXPA05013121A (es) | Derivados de indol con efecto de induccion de apoptosis. | |
MY187748A (en) | Compositions and method for maintaining/improving cognitive function | |
WO2012091425A3 (ko) | 4-하이드록시 타목시펜 유사체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는, 대사증후군 관련 질환의 예방 또는 치료용 조성물 | |
JP2015134867A (ja) | 抗酸化剤 | |
WO2004000043A3 (en) | Nutraceutic compositions and food supplements containing nadh | |
WO2014150959A3 (en) | Method and products for enhancing cellular uptake of drug and dietary supplements | |
IN2015DN03082A (el) |